Barclays’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $23.7M | Sell |
|
|||||
|
2025
Q2 | $27.3M | Buy |
|
|||||
|
2025
Q1 | $18M | Sell |
|
|||||
|
2024
Q4 | $23.4M | Sell |
|
|||||
|
2024
Q3 | $25.8M | Sell |
|
|||||
|
2024
Q2 | $34.1M | Buy |
|
|||||
|
2024
Q1 | $30.7M | Sell |
|
|||||
|
2023
Q4 | $40M | Sell |
|
|||||
|
2023
Q3 | $36.7M | Buy |
|
|||||
|
2023
Q2 | $31.3M | Buy |
|
|||||
|
2023
Q1 | $9.86M | Sell |
|
|||||
|
2022
Q4 | $14.5M | Sell |
|
|||||
|
2022
Q3 | $14.1M | Sell |
|
|||||
|
2022
Q2 | $27.6M | Buy |
|
|||||
|
2022
Q1 | $32.3M | Buy |
|
|||||
|
2021
Q4 | $31.2M | Buy |
|
|||||
|
2021
Q3 | $31.9M | Buy |
|
|||||
|
2021
Q2 | $24.9M | Buy |
|
|||||
|
2021
Q1 | $3.76M | Buy |
|
|||||
|
2020
Q4 | $338K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $82K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $1.28M | Buy |
|
|||||
|
2019
Q3 | $582K | Sell |
|
|||||
|
2019
Q2 | $1.04M | Sell |
|
|||||
|
2019
Q1 | $4.34M | Sell |
|
|||||
|
2018
Q4 | $4.51M | Buy |
|
|||||
|
2018
Q3 | $4.22M | Sell |
|
|||||
|
2018
Q2 | $8.12M | Buy |
|
|||||
|
2018
Q1 | $5.79M | Buy |
|
|||||
|
2017
Q4 | $2.09M | Buy |
|
|||||
|
2017
Q3 | $30K | Sell |
|
|||||
|
2017
Q2 | $107K | Sell |
|
|||||
|
2017
Q1 | $505K | Buy |
|
|||||
|
2016
Q4 | $96K | Sell |
|
|||||
|
2016
Q3 | $221K | Sell |
|
|||||
|
2016
Q2 | $1.27M | Sell |
|
|||||
|
2016
Q1 | $1.38M | Buy |
|
|||||
|
2015
Q4 | $1.25M | Sell |
|
|||||
|
2015
Q3 | $1.02M | Buy |
|
|||||
|
2015
Q2 | $109K | Buy |
|
|||||
|
2015
Q1 | $74K | Sell |
|
|||||
|
2014
Q4 | $138K | Sell |
|
|||||
|
2014
Q3 | $345K | Sell |
|
|||||
|
2014
Q2 | $762K | Buy |
|
|||||
|
2014
Q1 | $851K | Buy |
|
|||||
|
2013
Q4 | $688K | Sell |
|
|||||
|
2013
Q3 | $1.34M | Buy |
|
|||||
|
2013
Q2 | $303K | Buy |
|